Similar articles

• Erythrocyte membrane protein deficiencies in paroxysmal nocturnal hemoglobinuria.

  Schultz DR. Schultz DR. Am J Med. 1989 Sep;87(3N):22N-29N. Am J Med. 1989. PMID: 2484793 Review.
• Mechanisms by which the erythrocyte protects itself from complement damage.

  Nicholson-Weller A, Halperin JA. Nicholson-Weller A, et al. Prog Clin Biol Res. 1989;297:263-70; discussion 270-1. Prog Clin Biol Res. 1989. PMID: 2479950 No abstract available.
• Evidence that double transfection to xenoendothelial cells using GPI-anchoring complement regulatory factor (decay-accelerating factor and homologous restriction factor 20) gene is useful for the inhibition of human complement-mediated cytolysis.

  Hayashi S, Isobe K, Emi N, Okada H, Yasutomi M, Negita M, Koike C, Uchida K, Yokoyama I, Takagi H. Hayashi S, et al. Transplant Proc. 1995 Feb;27(1):330. Transplant Proc. 1995. PMID: 7533402 No abstract available.
• [Membrane-attacking complexes and membrane complement inhibitors on the leukocyte surface during combined exposure with meningococcus lipopolysaccharide and complement].

  Platonov AE, Vershinina IV, Serebrovskaia LV, Shepeleva GK. Platonov AE, et al. Biull Eksp Biol Med. 1999 Apr;127(4):433-8. Biull Eksp Biol Med. 1999. PMID: 10367130 Russian. No abstract available.
• Therapeutic inhibition of the complement system.

  Makrides SC. Makrides SC. Pharmacol Rev. 1998 Mar;50(1):59-87. Pharmacol Rev. 1998. PMID: 9549758 Review.